Market Overview

Why Livongo Health's Stock Is Trading Higher Today

Share:
Why Livongo Health's Stock Is Trading Higher Today

Livongo Health (NASDAQ: LVGO) shares are trading higher on Tuesday after Stephens initiated coverage on the stock with an Overweight rating and $95 price target. The company also raised its second-quarter sales guidance from $73-$75 million to $86-$87 million.

Livongo Health provides a data science and technology-enabled platform for detection of diabetes. Its additional solutions include Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength.

The company's clients comprise of employers, health plans, government entities, and labor unions. Its operations are primarily located in the U.S.

Livongo Health shares were trading up 21.15% at $94.05 at the time of publication on Tuesday. The stock has a 52-week high of $94.10 and a 52-week low of $15.12.

Related Links:

Livongo Health Shares Open Well Above IPO Price

Livongo Health IPO: What You Need To Know

Latest Ratings for LVGO

DateFirmActionFromTo
Aug 2020StifelDowngradesBuyHold
Aug 2020Canaccord GenuityMaintainsBuy
Aug 2020CitigroupMaintainsBuy

View More Analyst Ratings for LVGO
View the Latest Analyst Ratings

 

Related Articles (LVGO)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Guidance Price Target Initiation Analyst Ratings

Need corporate guidance data?
Click here to see licensing options.

Latest Ratings

StockFirmActionPT
BIIBRBC CapitalMaintains277.0
RLICompass PointInitiates Coverage On90.0
CSCOWolfe ResearchDowngrades42.0
NKEBarclaysMaintains132.0
GILDRBC CapitalMaintains86.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com